Skip to main content
All lobbying filings

THORN RUN PARTNERS

Lobbying for EXELIXIS · Genomics-based drug discovery company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

 Lobbying activity 2
Medicare/Medicaid

Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).

Health Issues

Policies related to creating incentives for innovation in the life sciences.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem